findmyKOL

Nilay Nahar, MD

Basic profile

University of Miami

ORCIDNone on fileNPI↗
✓ Full record
RegionJacksonville, FL · SoutheastSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL type: RegionalLatest publication2009Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Nilay Nahar is a Nephrology physician affiliated with University of Miami. OpenAlex indexes 5 publications with 537 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
5publications

Distinct works indexed by OpenAlex.

537citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
8companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2585 Herschel St
Jacksonville, FL 322044557

Telephone

904-388-2678

Provider last certified this registry record 29 Jun 2021.

View the NPPES registry record

Industry payments

8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    56.5%
    Beta blocker12.1%
    Carvedilol33%Labetalol Hcl29%Metoprolol Tartrate23%Metoprolol Succinate15%
    Part D<11 patients
    Calcium channel blocker10.9%
    Amlodipine Besylate57%Nifedipine Er43%
    Part D<11 patients

    + 9 more classes in this area

  • Other

    24.3%
    Phosphate Binder17.8%
    Sevelamer Carbonate100%
    Part D≥50 patients
    Drugs for treatment of hyperkalemia and hyperphosphatemia6.4%
    Velphoro100%
    Part D≥18 patients
  • Metabolism & gastrointestinal

    17.7%
    Vitamin D3 Analog5.9%
    Calcitriol100%
    Part D≥16 patients
    Serotonin-3 Receptor Antagonist3.4%
    Ondansetron Hcl61%Ondansetron Odt39%
    Part D<11 patients

    + 4 more classes in this area

Where care is delivered (Part B)57.1% facility · 42.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”